The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events

Journal of Cell Science

Volumn 117, Issue 3, 2004, Pages 373-380

  Thorne, Rick F ^a   Legg, James W ^b   Isacke, Clare M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MEDIMMUNE LTD   (United Kingdom)

Author keywords

CD44; ERM; Ezrin; Hyaluronan; Phosphorylation; Proteolytic cleavage

Indexed keywords

CELL RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; RNA;

ALTERNATIVE RNA SPLICING; ANTIGEN FUNCTION; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL INTERACTION; CELL JUNCTION; CELL MEMBRANE; CELL TYPE; CYTOPLASM; EXTRACELLULAR MATRIX; GENETIC CONSERVATION; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; CELL ADHESION; CELL ADHESION MOLECULES; CELL MEMBRANE; GLYCOSYLATION; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 0842280615     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00954     Document Type: Article

References (98)

1. Bajorath, J. (2000). Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 39, 103-111.
2. Bass, M. D. and Humphries, M. J. (2002). Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem. J. 368, 1-15.
3. Bates, R. C., Edwards, N. S., Burns, G. F. and Fisher, D. E. (2001). A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res. 61, 5275-5283.
4. Bazil, V. and Strominger, J. L. (1994). Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J. Immunol. 152, 1314-1322.
5. Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G. and Aruffo, A. (1995). CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128, 687-698.
6. Bijlmakers, M. J. and Marsh, M. (2003). The on-off story of protein palmitoylation. Trends Cell Biol. 13, 32-42.
7. Bourguignon, L. Y., Kalomiris, E. L. and Lokeshwar, V. B. (1991). Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J. Biol. Chem. 266, 11761-11765.
8. Bourguignon, L. Y., Zhu, H., Chu, A., Iida, N., Zhang, L. and Hung, M. C. (1997). Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J. Biol. Chem. 272, 27913-27918.
9. Bourguignon, L. Y., Zhu, H., Shao, L., Zhu, D. and Chen, Y. W. (1999). Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil. Cytoskeleton 43, 269-287.
10. Bourguignon, L. Y., Zhu, H., Shan, L. and Chen, Y. W. (2001). CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J. Biol. Chem. 276, 7327-7336.
11. Bretscher, A., Edwards, K. and Fehon, R. G. (2002). ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell. Biol. 3, 586-599.
12. Brown, M. S., Ye, J., Rawson, R. B. and Goldstein, J. L. (2000). Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398.
13. Calikoglu, E., Augsburger, E., Masouye, I., Chavaz, P., Saurat, J. H. and Kaya, G. (2002). Hyaluronate accumulation and decreased CD44 expression in perifollicular solitary cutaneous myxoma. Dermatology 205, 122-126.
14. Calikoglu, E., Chavaz, P., Saurat, J. H. and Kaya, G. (2003). Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma. Dermatology 207, 104-106.
15. Cao, X. and Sudhof, T. C. (2001). A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120.
16. Cichy, J. and Pure, E. (2003). The liberation of CD44. J. Cell Biol. 161, 839-843.
17. Culty, M., Nguyen, H. A. and Underhill, C. B. (1992). The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116, 1055-1062.
18. Day, A. J. and Prestwich, G. D. (2002). Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277, 4585-4588.
19. Gal, I., Lesley, J., Ko, W., Gonda, A., Stoop, R., Hyman, R. and Mikecz, K. (2003). Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow. J. Biol. Chem. 278, 11150-11158.
20. Gautreau, A., Louvard, D. and Arpin, M. (2002). ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin. Cell Biol. 14, 104-109.
21. Goldstein, L. A. and Butcher, E. C. (1990). Identification of mRNA that encodes an alternative form of H-CAM (CD44) in lymphoid and nonlymphoid tissues. Immunogenetics 32, 389-397.
22. Goldstein, L. A., Zhou, D. F., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F. and Butcher, E. C. (1989). A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56, 1063-1072.
23. Granes, F., Urena, J. M., Rocamora, N. and Vilaro, S. (2000). Ezrin links syndecan-2 to the cytoskeleton. J. Cell Sci. 113, 1267-1276.
24. Guo, Y. J., Lin, S. C., Wang, J. H., Bigby, M. and Sy, M. S. (1994). Palmitoylation of CD44 interferes with CD3-mediated signaling in human T lymphocytes. Int. Immunol. 6, 213-221.
25. Hamada, K., Shimizu, T., Matsui, T., Tsukita, S. and Hakoshima, T. (2000). Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19, 4449-4462.
26. Hamada, K., Shimizu, T., Yonemura, S., Tsukita, S. and Hakoshima, T. (2003). Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-1CAM-2 complex. EMBO J. 22, 502-514.
27. Heilker, R., Spiess, M. and Crottet, P. (1999). Recognition of sorting signals by clathrin adaptors. Bioessays 21, 558-567.
28. Heiska, L., Alfthan, K., Gronholm, M., Vilja, P., Vaheri, A. and Carpen, O. (1998). Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J. Biol. Chem. 273, 21893-21900.
29. Helander, T. S., Carpen, O., Turunen, O., Kovanen, P. E., Vaheri, A. and Timonen, T. (1996). ICAM-2 redistributed by ezrin as a target for killer cells. Nature 382, 265-268.
30. Horowitz, A., Tkachenko, E. and Simons, M. (2002). Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J. Cell Biol. 157, 715-725.
31. Hung, A. Y. and Sheng, M. (2002). PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277, 5699-5702.
32. Ilangumaran, S., Briol, A. and Hoessli, D. C. (1998). CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood 91, 3901-3908.
33. Isacke, C. M. (1994). The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107, 2353-2359.
34. Isacke, C. M. and Yarwood, H. (2002). The hyaluronan receptor, CD44. Int. J. Biochem. Cell Biol. 34, 718-721.
35. Ivetic, A., Deka, J., Ridley, A. and Ager, A. (2002). The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin. J. Biol. Chem. 277, 2321-2329.
36. Jiang, H., Knudson, C. B. and Knudson, W. (2001). Antisense inhibition of CD44 tailless splice variant in human articular chondrocytes promotes hyaluronan internalization. Arthritis Rheum. 44, 2599-2610.
37. Jones, M., Tussey, L., Athanasou, N. and Jackson, D. G. (2000). Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J. Biol. Chem. 275, 7964-7974.
38. Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H. and Seiki, M. (2001). Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153, 893-904.
39. Kawano, Y., Okamoto, I., Murakami, D., Itoh, H., Yoshida, M., Ueda, S. and Saya, H. (2000). Ras oncoprotein induces CD44 cleavage through phosphoinositide 3-OH kinase and the rho family of small G proteins. J. Biol. Chem. 275, 29628-29635.
40. Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P. and Stamenkovic, I. (1997). Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 11, 996-1007.
41. Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P. and Stamenkovic, I. (1999). Cutaneous delayed-type hypersensitivity response is inhibited in transgenic mice with keratinocyte-specific CD44 expression defect. J. Invest. Dermatol. 113, 137-138.
42. Kaya, G., Augsburger, E., Stamenkovic, I. and Saurat, J. H. (2000). Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. J. Invest. Dermatol. 115, 1054-1058.
43. Kincade, P. W., Zheng, Z., Katoh, S. and Hanson, L. (1997). The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9, 635-642.
44. Knudson, W., Chow, G. and Knudson, C. B. (2002). CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 21, 15-23.
45. Lammich, S., Okochi, M., Takeda, M., Kaether, C., Capell, A., Zimmer, A. K., Edbauer, D., Walter, J., Steiner, H. and Haass, C. (2002). Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide. J. Biol. Chem. 277, 44754-44759.
46. Legg, J. W. and Isacke, C. M. (1998). Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr. Biol. 8, 705-708.
47. Legg, J. W., Lewis, C. A., Parsons, M., Ng, T. and Isacke, C. M. (2002). A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat. Cell Biol. 4, 399-407.
48. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R. and Kincade, P. W. (1992). Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175, 257-266.
49. Lesley, J., Hyman, R. and Kincade, P. W. (1993). CD44 and its interaction with extracellular matrix. Adv. Immunol. 54, 271-335.
50. Lesley, J., Hyman, R., English, N., Catterall, J. B. and Turner, G. A. (1997). CD44 in inflammation and metastasis. Glycoconjugate J. 14, 611-622.
51. Lesley, J., English, N., Charles, C. and Hyman, R. (2000). The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. Eur. J. Immunol. 30, 245-253.
52. Lewis, C. A., Townsend, P. A. and Isacke, C. M. (2001). Ca(2+)/calmodulin-dependent protein kinase mediates the phosphorylation of CD44 required for cell migration on hyaluronan. Biochem. J. 357, 843-850.
53. Mangeat, P., Roy, C. and Martin, M. (1999). ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol. 9, 187-192.
54. Martin, T. A., Harrison, G., Mansel, R. E. and Jiang, W. G. (2003). The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol. 46, 165-186.
55. Mori, H., Tomari, T., Koshikawa, N., Kajita, M., Itoh, Y., Sato, H., Tojo, H., Yana, I. and Seiki, M. (2002). CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 21, 3949-3959.
56. Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H. and Herrlich, P. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15, 968-980.
57. Murakami, D., Okamoto, I., Nagano, O., Kawano, Y., Tomita, T., Iwatsubo, T., de Strooper, B., Yumoto, E. and Saya, H. (2003). Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene 22, 1511-1516.
58. Naor, D., Sionov, R. V. and Ish-Shalom, D. (1997). CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241-319.
59. Neame, S. J. and Isacke, C. M. (1992). Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J. 11, 4733-4738.
60. Neame, S. J., Uff, C. R., Sheikh, H., Wheatley, S. C. and Isacke, C. M. (1995). CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J. Cell Sci. 108, 3127-3135.
61. Ng, T., Parsons, M., Hughes, W. E., Monypenny, J., Zicha, D., Gautreau, A., Arpin, M., Gschmeissner, S., Verveer, P. J., Bastiaens, P. I. et al. (2001). Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 20, 2723-2741.
62. Noble, P. W. (2002). Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21, 25-29.
63. Okamoto, I., Kawano, Y., Tsuiki, H., Sasaki, J., Nakao, M., Matsumoto, M., Suga, M., Ando, M., Nakajima, M. and Saya, H. (1999a). CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 18, 1435-1446.
64. Okamoto, L, Kawano, Y., Matsumoto, M., Saga, M., Kaibuchi, K., Ando, M. and Saya, H. (1999b). Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J. Biol. Chem. 274, 25525-25534.
65. Okamoto, I., Kawano, Y., Murakami, D., Sasayama, T., Araki, N., Miki, T., Wong, A. J. and Saya, H. (2001). Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155, 755-762.
66. Okamoto, I., Tsuiki, H., Kenyon, L. C., Godwin, A. K., Emlet, D. R., Holgado-Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T., Guha, A. et al. (2002). Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am. J. Pathol. 160, 441-447.
67. Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwarzler, C., Schwarz, H., Beug, H., Gunthert, U. and Huber, L. A. (1999). Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J. Cell Biol. 146, 843-854.
68. Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P. and Ponta, H. (2002). CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16, 3074-3086.
69. Pearson, M. A., Reczek, D., Bretscher, A. and Karplus, P. A. (2000). Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101, 259-270.
70. Peck, D. and Isacke, C. M. (1996). CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr. Biol. 6, 884-890.
71. Peck, D. and Isacke, C. M. (1998). Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325. J. Cell Sci. 111, 1595-1601.
72. Perschl, A., Lesley, J., English, N., Hyman, R. and Trowbridge, I. S. (1995a). Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 108, 1033-1041.
73. Perschl, A., Lesley, J., English, N., Trowbridge, I. and Hyman, R. (1995b). Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 25, 495-501.
74. Ponta, H., Sherman, L. and Herrlich, P. A. (2003). CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 4, 33-45.
75. Pure, E. and Cuff, C. A. (2001). A crucial role for CD44 in inflammation. Trends Mol. Med. 7, 213-221.
76. Pure, E., Camp, R. L., Peritt, D., Panettieri, R. A., Jr, Lazaar, A. L. and Nayak, S. (1995). Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181, 55-62.
77. Roscic-Mrkic, B., Fischer, M., Leemann, C., Manrique, A., Gordon, C. J., Moore, J. P., Proudfoot, A. E. and Trkola, A. (2003). RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102, 1169-1177.
78. Serrador, J. M., Nieto, M., Alonso-Lebrero, J. L., del Pozo, M. A., Calvo, J., Furthmayr, H., Schwartz-Albiez, R., Lozano, F., Gonzalez-Amaro, R., Sanchez-Mateos, P. et al. (1998). CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood 91, 4632-4644.
79. Sheikh, H. and Isacke, C. M. (1996). A di-hydrophobic Leu-Val motif regulates the basolateral localization of CD44 in polarized Madin-Darby canine kidney epithelial cells. J. Biol. Chem. 271, 12185-12190.
80. Sherman, L., Wainwright, D., Ponta, H. and Herrlich, P. (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev. 12, 1058-1071.
81. Sherman, L. S., Rizvi, T. A., Karyala, S. and Ratner, N. (2000). CD44 enhances neuregulin signaling by Schwann cells. J. Cell Biol. 150, 1071-1084.
82. Shi, M., Dennis, K., Peschon, J. J., Chandrasekaran, R. and Mikecz, K. (2001). Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton. J. Immunol. 167, 123-131.
83. Slevin, M., Kumar, S. and Gaffney, J. (2002). Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J. Biol. Chem. 277, 41046-41059.
84. Steiner, H. and Haass, C. (2000). Intramembrane proteolysis by presenilins. Nat. Rev. Mol. Cell. Biol. 1, 217-224.
85. Taher, T. E., Smit, L., Griffioen, A. W., Schilder-Tol, E. J., Borst, J. and Pals, S. T. (1996). Signaling through CD44 is mediated by tyrosine kinases. Association with p561ck in T lymphocytes. J. Biol. Chem. 271, 2863-2867.
86. Tammi, M. I., Day, A. J. and Turley, E. A. (2002). Hyaluronan and homeostasis: A balancing act. J. Biol. Chem. 277, 4581-4584.
87. Tammi, R., Rilla, K., Pienimaki, J. P., MacCallum, D. K., Hogg, M., Luukkonen, M., Hascall, V. C. and Tammi, M. (2001). Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 276, 35111-35122.
88. Tanaka, Y., Adams, D. H., Hubscher, S., Hirano, H., Siebenlist, U. and Shaw, S. (1993). T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361, 79-82.
89. Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Pure, E., Henson, P. M. and Noble, P. W. (2002). Resolution of lung inflammation by CD44. Science 296, 155-158.
90. Thomas, L., Byers, H. R., Vink, J. and Stamenkovic, I. (1992). CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118, 971-977.
91. Toole, B. P., Wight, T. N. and Tammi, M. I. (2002). Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 277, 4593-4596.
92. Turley, E. A., Noble, P. W. and Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. J. Biol. Chem. 277, 4589-4592.
93. Turunen, O., Sainio, M., Jaaskelainen, J., Carpen, O. and Vaheri, A. (1998). Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein. Biochim. Biophys. Acta 1387, 1-16.
94. van der Voort, R., Taher, T. E., Wielenga, V. J., Spaargaren, M., Prevo, R., Smit, L., David, G., Hartmann, G., Gherardi, E. and Pals, S. T. (1999). Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 274, 6499-6506.
95. Weber, G. F., Ashkar, S., Glimcher, M. J. and Cantor, H. (1996). Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271, 509-512.
96. Xu, Y. and Yu, Q. (2003). E-cadherin negatively regulates CD44-hyaluronan interaction and CD44-mediated tumor invasion and branching morphogenesis. J. Biol. Chem. 278, 8661-8668.
97. Yonemura, S., Hirao, M., Doi, Y., Takahashi, N., Kondo, T. and Tsukita, S. (1998). Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 140, 885-895.
98. Yu, W. H., Woessner, J. F., Jr, McNeish, J. D. and Stamenkovic, I. (2002). CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307-323.